## Abstract Recent evidence indicates that in chronic experimental autoimmune myasthenia gravis (EAMG) and in human myasthenia gravis, the defect of neuromuscular transmission results from immuneβmediated destruction of postsynaptic membrane at the neuromuscular junction, with a reduction in the de
Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits
β Scribed by Giovanni Levi; Rebecca Tarrab-Hazdai; Vivian I. Teichberg
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 895 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Two patients who underwent plamsapheresis for severe myasthenia gravis showed marked exacerbation of myasthenic weakness at the end of exchange sessions, in which citrate was used for anticoagulation. In one pa- tient, improvement occurred after the administration of calcium but not after edrophoniu
## Antigen-specific therapy of experimental myasthenia gravis with acetylcholine receptor-gelonin conjugates in viva* Rats suffering from experimental autoimmune myasthenia gravis (EAMG) induced by previous immunization with foreign acetylcholine receptor (AChR) were treated with AChR-toxin conjug
A test for diminished neuromuscular function in animals with experimental autoimmune myasthenia gravis is described. Within minutes following an injection of gallamine triethiodide, mice exhibit a dramatic yet transient response which is dose-dependent. Mice previously inoculated with acetylcholine